EUVIMEDEUVIMED entdecken
Crossref

BRAF/TERT Co-Mutations in Radioiodine-Refractory Differentiated Thyroid Cancer: Association with Aggressive Clinicopathological Features

A. Rakhmankulova, L. Pak

European Journal of Cancer · 2026-11 · 248 · 117542

DOI: 10.1016/j.ejca.2026.117542 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von A. Rakhmankulova und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Rakhmankulova, A., & Pak, L. (2026). BRAF/TERT Co-Mutations in Radioiodine-Refractory Differentiated Thyroid Cancer: Association with Aggressive Clinicopathological Features. European Journal of Cancer, 248, 117542. https://doi.org/10.1016/j.ejca.2026.117542

Vancouver

Rakhmankulova A, Pak L. BRAF/TERT Co-Mutations in Radioiodine-Refractory Differentiated Thyroid Cancer: Association with Aggressive Clinicopathological Features. European Journal of Cancer. 2026;248:117542. doi:10.1016/j.ejca.2026.117542

BibTeX
@article{Rakhmankulova2026,
  author = {Rakhmankulova, A. and Pak, L.},
  title = {BRAF/TERT Co-Mutations in Radioiodine-Refractory Differentiated Thyroid Cancer: Association with Aggressive Clinicopathological Features},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {248},
  pages = {117542},
  doi = {10.1016/j.ejca.2026.117542}
}
Kostenlos starten →